IκB kinaseα/β control biliary homeostasis and hepatocarcinogenesis in mice by phosphorylating the cell‐death mediator receptor‐interacting protein kinase 1

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Hepatology

• Publication date

  2016-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/hep.28723PMID 27396433
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The microbiome and cancer

  2018cited by this paper
• NF-k B-Independent Role o f IKK a / IKK b in Preventing RIPK 1 Kinase-Dependent Apoptotic and Necroptotic Cell Death during TNF Signaling Graphical Abstract Highlights

  2015cited by this paper
• Receptor interacting protein kinase 1 mediates murine acetaminophen toxicity independent of the necrosome and not through necroptosis

  2015cited by this paper
• Abstract B27: RIP1 maintains DNA integrity and cell proliferation by regulating PGC-1α-mediated mitochondrial oxidative phosphorylation and glycolysis

  2015cited by this paper
• NEMO Prevents Steatohepatitis and Hepatocellular Carcinoma by Inhibiting RIPK1 Kinase Activity-Mediated Hepatocyte Apoptosis

  2015cited by this paper
• Cell death and cell death responses in liver disease: mechanisms and clinical relevance.

  2014cited by this paper
• Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3.

  2014cited by this paper
• Regulated necrosis: the expanding network of non-apoptotic cell death pathways

  2014cited by this paper
• Caspase-8 and RIP kinases regulate bacteria-induced innate immune responses and cell death

  2014cited by this paper
• The two faces of receptor interacting protein kinase-1.

  2014cited by this paper
• Cell-type-resolved quantitative proteomics of murine liver.

  2014cited by this paper
• RIPK1 maintains epithelial homeostasis by inhibiting apoptosis and necroptosis

  2014cited by this paper
• The microbiome and cancer

  2013cited by this paper
• RIP3 inhibits inflammatory hepatocarcinogenesis but promotes cholestasis by controlling caspase-8- and JNK-dependent compensatory cell proliferation.

  2013cited by this paper
• Positive and negative phosphorylation regulates RIP1- and RIP3-induced programmed necrosis.

  2013influential reference
• DNA Damage Sensor γ-H2AX Is Increased in Preneoplastic Lesions of Hepatocellular Carcinoma

  2013cited by this paper
• Regulation of RIP1 kinase signalling at the crossroads of inflammation and cell death

  2013cited by this paper
• Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease models

  2012cited by this paper
• Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4.

  2012cited by this paper
• The 'complexities' of life and death: death receptor signalling platforms.

  2012influential reference
• Regulation of cell death and autophagy by IKK and NF‐κB: critical mechanisms in immune function and cancer

  2012cited by this paper
• TRAIL induces necroptosis involving RIPK1/RIPK3-dependent PARP-1 activation

  2012cited by this paper
• Management of hepatocellular carcinoma: An update

  2011cited by this paper
• Inflammation meets cancer, with NF-κB as the matchmaker

  2011cited by this paper
• γH2AX: a sensitive molecular marker of DNA damage and repair

  2010cited by this paper
• The Role of the Kinases RIP1 and RIP3 in TNF-Induced Necrosis

  2010influential reference
• TAK1 suppresses a NEMO-dependent but NF-kappaB-independent pathway to liver cancer.

  2010influential reference
• Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation.

  2009influential reference
• Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha.

  2009cited by this paper
• Death receptor signal transducers: nodes of coordination in immune signaling networks

  2009influential reference
• Contradictory functions of NF-kappaB in liver physiology and cancer.

  2008cited by this paper
• IKK1 and IKK2 cooperate to maintain bile duct integrity in the liver

  2008influential reference
• MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification

  2008cited by this paper
• IKKalpha is required to maintain skin homeostasis and prevent skin cancer.

  2008cited by this paper
• Identification of RIP1 kinase as a specific cellular target of necrostatins.

  2008cited by this paper
• Deletion of NEMO/IKKγ in Liver Parenchymal Cells Causes Steatohepatitis and Hepatocellular Carcinoma

  2007cited by this paper
• Deletion of NEMO/IKKgamma in liver parenchymal cells causes steatohepatitis and hepatocellular carcinoma.

  2007cited by this paper
• Genetic inactivation of RelA/p65 sensitizes adult mouse hepatocytes to TNF-induced apoptosis in vivo and in vitro.

  2007cited by this paper
• Poly(ADP-ribose) Polymerase-1 Signaling to Mitochondria in Necrotic Cell Death Requires RIP1/TRAF2-mediated JNK1 Activation*

  2006cited by this paper
• Regulation and Function of IKK and IKK-Related Kinases

  2006cited by this paper
• IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis.

  2005cited by this paper
• Kinase RIP3 Is Dispensable for Normal NF-κBs, Signaling by the B-Cell and T-Cell Receptors, Tumor Necrosis Factor Receptor 1, and Toll-Like Receptors 2 and 4

  2004cited by this paper
• Signaling to NF-kappaB.

  2004cited by this paper
• ATM Phosphorylates Histone H2AX in Response to DNA Double-strand Breaks*

  2001cited by this paper
• IKKalpha provides an essential link between RANK signaling and cyclin D1 expression during mammary gland development.

  2001cited by this paper
• IKKα Provides an Essential Link between RANK Signaling and Cyclin D1 Expression during Mammary Gland Development

  2001cited by this paper
• Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway.

  2001cited by this paper
• Activation by IKKα of a Second, Evolutionary Conserved, NF-κB Signaling Pathway

  2001cited by this paper
• Hepatocyte‐specific expression of Cre recombinase

  2000cited by this paper
• American Association for the Study of Liver Diseases

  1959cited by this paper

• A decision point between transdifferentiation and programmed cell death priming controls KRAS-dependent pancreatic cancer development

  2025cites this paper
• ToIκB and ToIKK Genes from Golden Pompano (Trachinotus ovatus): Molecular Characterization, Expression, and Association with Tolerance to Streptococcus agalactiae Infection.

  2025cites this paper
• Sublethal necroptosis signaling promotes inflammation and liver cancer.

  2023cites this paper
• Cellular Homeostasis and Repair in the Biliary Tree.

  2022cites this paper
• Hepatocyte Bcl-3 protects from death-receptor mediated apoptosis and subsequent acute liver failure

  2022cites this paper
• RIP1 post-translational modifications.

  2022cites this paper
• Regulation of Inflammatory Cell Death by Phosphorylation

  2022cites this paper
• Suppression of RIP1 activity via S415 dephosphorylation ameliorates obesity‐related hepatic insulin resistance

  2022cites this paper
• The lncRNA CASC2 Modulates Hepatocellular Carcinoma Cell Sensitivity and Resistance to TRAIL Through Apoptotic and Non-Apoptotic Signaling

  2022cites this paper
• IKKβ Alleviates Neuron Injury in Alzheimer’s Disease via Regulating Autophagy and RIPK1-Mediated Necroptosis

  2022cites this paper
• Liver Fibrosis—From Mechanisms of Injury to Modulation of Disease

  2022cites this paper
• Apolipoprotein A1 Protects Against Necrotic Core Development in Atherosclerotic Plaques: PDZK1-Dependent High-Density Lipoprotein Suppression of Necroptosis in Macrophages

  2022cites this paper
• Fas/FasL mediates NF-κBp65/PUMA-modulated hepatocytes apoptosis via autophagy to drive liver fibrosis

  2021cites this paper
• Immune dysregulation in SHARPIN-deficient mice is dependent on CYLD-mediated cell death

  2021cites this paper
• Necroptosis in Pulmonary Diseases: A New Therapeutic Target

  2021influential citation
• Phosphorylation of NF-κBp65 drives inflammation-mediated hepatocellular carcinogenesis and is a novel therapeutic target

  2021cites this paper
• Deletion of mTOR in liver epithelial cells enhances hepatic metastasis of colon cancer

  2021cites this paper
• Receptor-interacting protein in malignant digestive neoplasms

  2021cites this paper
• JNK signaling prevents biliary cyst formation through a CASPASE-8–dependent function of RIPK1 during aging

  2021cites this paper
• Protective effect of Gloeostereum incarnatum on ulcerative colitis via modulation of Nrf2/NF-κB signaling in C57BL/6 mice

  2020cites this paper
• RIPK1 Kinase-Dependent Death: A Symphony of Phosphorylation Events.

  2020cites this paper
• Reversal of CYLD phosphorylation as a novel therapeutic approach for adult T-cell leukemia/lymphoma (ATLL)

  2020cites this paper
• Immune dysregulation in SHARPIN-deficient mice is dependent on CYLD-mediated cell death

  2020cites this paper
• The IKKβ‐USP30‐ACLY Axis Controls Lipogenesis and Tumorigenesis

  2020cites this paper
• Life, death, and autophagy in cancer: NF-κB turns up everywhere

  2020cites this paper
• Necroptosis in Cholangiocarcinoma

  2020cites this paper
• Enhanced inflammatory response mediated by parenchymal cells associates with resistance towards mTOR inhibition

  2020cites this paper
• The phospho-barcode of RIPK1: complementarity or redundancy?

  2020cites this paper
• 25 years of research put RIPK1 in the clinic.

  2020cites this paper
• An NF-kappaB- and IKK-Independent Function of NEMO Prevents Hepatocarcinogenesis by Suppressing Compensatory Liver Regeneration

  2019cites this paper
• RIP Kinases in Liver Cell Death, Inflammation and Cancer.

  2019cites this paper
• Nuclear Translocation of RELB Is Increased in Diseased Human Liver and Promotes Ductular Reaction and Biliary Fibrosis in Mice.

  2019cites this paper
• Targeting IκappaB kinases for cancer therapy.

  2019cites this paper
• Necroptotic Cell Death in Liver Transplantation and Underlying Diseases: Mechanisms and Clinical Perspective

  2019cites this paper
• RIPK1 and death receptor signaling drive biliary damage and early liver tumorigenesis in mice with chronic hepatobiliary injury

  2019cites this paper
• Current translational potential and underlying molecular mechanisms of necroptosis

  2019cites this paper
• An IKK/NF-κB Activation/p53 Deletion Sequence Drives Liver Carcinogenesis and Tumor Differentiation

  2019cites this paper
• Serine 25 phosphorylation inhibits RIPK1 kinase-dependent cell death in models of infection and inflammation

  2019cites this paper
• Necroptosis in development and diseases

  2018cites this paper
• A novel IKBKG mutation in a patient with incontinentia pigmenti and features of hepatic ciliopathy

  2018cites this paper
• The Receptor Interacting Protein Kinases in the Liver

  2018cites this paper
• Roles of TRAFs in NF-κB signaling pathways mediated by BAFF.

  2018cites this paper
• MK2 puts an additional brake on RIPK1 cytotoxic potential

  2018cites this paper
• Apoptosis and necroptosis in the liver: a matter of life and death

  2018cites this paper
• Effect of luteolin on HepG2 liver cancer cell proliferation in vitro and angiogenesis activity

  2018cites this paper
• IKK1/2 protect human cells from TNF-mediated RIPK1-dependent apoptosis in an NF-κB-independent manner.

  2018cites this paper
• RIPK1, a key survival factor for hepatocytes.

  2017cites this paper
• NF-κB Members Left Home: NF-κB-Independent Roles in Cancer

  2017cites this paper
• p38MAPK/MK2-dependent phosphorylation controls cytotoxic RIPK1 signalling in inflammation and infection

  2017cites this paper
• Hepatocyte Death in Liver Inflammation, Fibrosis, and Tumorigenesis

  2017cites this paper
• Inflammation and the Metabolic Syndrome: The Tissue-Specific Functions of NF-κB.

  2017cites this paper
• RIPK1 Suppresses a TRAF2-Dependent Pathway to Liver Cancer.

  2017cites this paper
• The interplay of IKK, NF‐κB and RIPK1 signaling in the regulation of cell death, tissue homeostasis and inflammation

  2017cites this paper
• The enigma of RIPK1 in the liver: More than just a kinase

  2017cites this paper
• MK2 phosphorylation of RIPK1 regulates TNF-mediated cell death

  2017cites this paper
• Kinase-independent functions of RIPK1 regulate hepatocyte survival and liver carcinogenesis

  2017cites this paper